The MRF's Scientific Leadership

The MRF’s Scientific Leadership is comprised of multidisciplinary experts in basic and translational research, dermatology, epidemiology, genomics, pathology, surgery and medical oncology. 
Members of the MRF’s Scientific Advisory Committee (SAC) are listed below. Learn more about the Scientific Steering Committee behind the MRF’s CURE OM initiative and the MRFBC's Steering Committee. To read more about the MRF’s melanoma research and science objectives, visit our Research Center


Michael B. Atkins, M.D., Ph.D.

Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center
Georgetown University
Washington, D.C.

Ze'ev A. Ronai, Ph.D.

Professor and Scientific Director
Deputy Director, NCI Cancer Center
Sanford Burnham Medical Research Institute
La Jolla, California


Andrew Aplin, Ph.D.

Program Leader for Cancer Cell Biology and Signaling, Kimmel Cancer Center, Thomas Jefferson University
Thomas Jefferson University 
Philadelphia, Pennsylvania

Boris C. Bastian, M.D.

Professor of Dermatology and Pathology
Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Biology
University of California, San Francisco 
San Francisco, California

Marianne Berwick, Ph.D., M.P.H.

Professor and Chief, Division of Epidemiology
Head, Epidemiology and Cancer Prevention
University of New Mexico
Albuquerque, New Mexico

Kevin Brown, Ph.D.

Laboratory of Translational Genomics
Bethesda, Maryland

Paul B. Chapman, M.D.

Attending Physician, Melanoma/Sarcoma Service
Department of Medicine, Memorial Sloan-Kettering Cancer Center
Professor of Medicine, Weill-Cornell Medical School
New York, New York

Alistair J. Cochran, M.D.

Departments of Pathology and Laboratory Medicine and Surgery
David Geffen School of Medicine at UCLA
University of California, Los Angeles
Los Angeles, California

Clara Curiel, M.D. 

Associate Professor of Dermatology
The University of Arizona Cancer Center
Tucson, Arizona

David E. Fisher, M.D., Ph.D.

Director, Melanoma Program and Chief, Department of Dermatology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Keith T. Flaherty, M.D.

Director, Developmental Therapeutics
Massachusetts General Hospital
Boston, Massachusetts

Alan Geller, MPH, RN

Senior Lecturer on Social and Behavioral Sciences
Department of Social and Behavioral Sciences
Harvard School of Public Health
Boston, Massachusetts

Jeff Gershenwald, M.D.

Professor, Department of Surgical Oncology, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX

Elizabeth A. Grimm, Ph.D.

Frances King Black Memorial Professor of Cancer Research
Department of Experimental Therapeutics and Melanoma Medical Oncology
University of Texas, MD Anderson Cancer Center
Houston, Texas

Ruth Halaban, Ph.D. 

Senior Research Scientist
Yale University School of Medicine
Department of Dermatology
New Haven, Connecticut

Allan Halpern, M.D.

Chief, Dermatology Service
Memorial Sloan-Kettering Cancer Center
New York, New York

Mary J.C. Hendrix, Ph.D.

President and Scientific Director
Medical Research Institute Council Professor
Children’s Memorial Research Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Dorothee Herlyn, D.V.M., D.Sc. (Grant SRO)

Professor Emeritus 
The Wistar Institute
Philadelphia, Pennsylvania

Meenhard Herlyn, D.V.M., D.Sc.

Professor and Program Leader, Molecular and Cellular Oncogenesis Program
The Wistar Institute
Philadelphia, Pennsylvania

Patrick Hwu, M.D.

Professor and Chair
Department of Melanoma Medical Oncology
University of Texas, MD Anderson Cancer Center
Houston, Texas

Howard L. Kaufman, M.D., F.A.C.S.

Director, Rush Cancer Center Program
Rush University Medical Center
Chicago, Illinois

John Kirkwood, M.D.

Professor, Department of Medicine
Co-Leader, Melanoma Program
University of Pittsburgh
Pittsburgh, Pennsylvania

Randy Lomax, M.A., M.F.T.

Chair Emeritus, Melanoma Research Foundation
San Francisco, California

Martin McMahon, Ph.D.

Assistant Director of Professional Education
Co-Leader Developmental Therapeutics Program
UCSF Helen Diller Family Comprehensive Cancer Center
Sanfrancisco, California

Glenn Merlino, Ph.D.

Head, Cancer Modeling Section
Chief, Laboratory of Cancer Biology and Genetics
Center for Cancer Research
National Cancer Institute
Bethesda, Maryland

Daniel Pinkel, Ph.D.

Professor, Department of Laboratory Medicine
UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Toni Ribas, M.D., Ph.D.

Co-Leader, Research Education, Training and Career Development Program (CTSI-ED)
Professor of Medicine, Hematology-Oncology
Professor of Surgery, Surgical Oncology
Associate Director, JCCC Tumor Immunology Program Area
Professor, Molecular and Medical Pharmacology
Los Angeles, California

Lynn Schuchter, M.D.

Chief, Hematology/Oncology, Professor of Medicine
Leader: Melanoma Program
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania

Mario Sznol, M.D. 

Professor of Medicine, Medical Oncology
Clinical Research Program Leader, Melanoma Program
Co-Director, Yale SPORE in Skin Cancer
Yale Cancer Center
New Haven, Connecticut

Vernon K. Sondak, M.D.

Department Chair, Cutaneous Oncology
Director of Surgical Education
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida

Jeff Sosman, M.D. 

Professor of Medicine (Hematology/Oncology)
Director, Melanoma & Tumor Immunotherapy Program
Co-Leader, VICC Signal Transduction & Cell Proliferation Research Program
Medical Oncologist at Vanderbilt-Ingram Cancer Center
Nashville, Tennessee

Nancy E. Thomas, M.D., Ph.D.

Associate Professor
Department of Dermatology
University of North Carolina
Chapel Hill, North Carolina

Jeffrey Weber, M.D., Ph.D.

Director, Donald A. Adam Comprehensive Melanoma Research Center
Senior Member, H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida

ex-officio Member:

Alison Martin, M.D.

Chief Medical Officer, MRFBC
Washington, D.C.